IPO Date: Oct 9 to Oct 13 2025
Listing Date: Oct 16 2025
1. Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company
2. Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
Medone House, B-75 Road No. 33 Wagle Estate, Thane (West)
Thane
Maharashtra
400604
022- 61414000
secretarial@rubicon.co.in
www.rubicon.co.in
MUFG Intime India Pvt Ltd.
In compliance of Regulation 30(6) and 30(13) of SEBI Listing Regulations, read with SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 and SEBI Circular HO/CFD/CFD-PoD-2/P/CIR/2025/25 dated 30th January 2026 and 25th February 2025 respectively (SEBI Circulars), as amended from time to time, Rubicon Research has informed that the Company has received an Assessment Order for the AY 2023-24 from Income Tax Authority. The details as required under the Listing Regulations and SEBI Circulars are provided in ‘Annexure A’ with this intimation. The company has also stated and declared that the information and details provided in Annexure A, in compliance with Regulation 30(13) of the SEBI Listing Regulations, is true, correct and complete to the best of its knowledge and belief. The order was received from Income Tax Authority on 21st April 2026 at 04:03 PM (IST). Following an internal evaluation of the order and its potential financial impact on the Company, the matter is being disclosed.
The above information is a part of company’s filings submitted to BSE.
Nilachal Carbo Metalicks has informed about Resignation of Independent Director Mr. Lala Tarun Prakash Narayan due to personal reasons.
The above information is a part of company’s filings submitted to BSE.
Entero Healthcare Solutions has informed about Resignation of Mr. Kevin Rohitbhai Daftary as Non- Executive Nominee Director of the company w.e.f. Jun 12, 2026.
The above information is a part of company’s filings submitted to BSE.
Silver Oak India has submitted Intimation of appointment of CS Anshika Singhai as the Company Secretary and Compliance Officer of the Company with effect from 12th June, 2026.
The above information is a part of company’s filings submitted to BSE.
Sukhjit Starch & Chemicals has informed that CRISIL has revised the credit rating of the company for Long Term Bank facilities and Fixed Deposits from CRISIL A+/Negative to CRISIL A / Stable. The credit rating for Short Term Bank facilities has be reaffirmed as CRISIL A1.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Rubicon Research Ltd. IPO is ₹758.61 - 798.10 crore.
The Rubicon Research Ltd. IPO opens for subscription on 2025-10-09 and closes on 2025-10-13.
The price range of Rubicon Research Ltd. IPO is ₹461.00 to ₹485.00.
The lot size of Rubicon Research Ltd. IPO is 30 shares.
The registrar of Rubicon Research Ltd. IPO is MUFG Intime India Pvt Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.